Source MS Trust: New research has provided the strongest evidence yet that infection with the Epstein Barr virus (EBV) acts as a trigger for people to develop MS.
Source MS Society: Last year, we announced a new trial testing if a drug called cladribine can slow down the worsening of arm and hand movement for people with advanced primary or secondary progressive MS.
Source MS Trust: Researchers wanted to find out if there are hidden patterns in MRI brain scans taken over time that would better identify biological differences in MS activity and detect progression earlier.
Source MS Society: We’re pleased to introduce Octopus - our revolutionary, multi-arm, multi-stage trial that will transform the way we test treatments for progressive MS.
Source MS Society: The Medicines and Healthcare products Regulatory Agency (MHRA), and European Commission (EC) have licenced ofatumumab to treat adults with active relapsing MS.
